CRT 2024
Innovation
BRS, DES and DCB Technologies [Non-CME]
Aloke V. Finn, MD
Medical Director CVPath/Assoc. Prof. Of Medicine University of Maryland
CVPath
Gaithersburg, Maryland, United States
No relationships to disclose
Bernardo Cortese, MD, FESC, FSCAI
consultant Cardiologist
Fondazione Ricerca e Innovazione Cardiovascolare
Milano, Lombardia, Italy
Disclosure information not submitted.
Bruno Scheller, MD
Professor of Clinical and Experimental Interventional Cardiology
University of Saarland
Homburg, Saarland, Germany
Disclosure(s): B.Braun: Clinical Trial Investigator (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); InnoRa GmbH: Major Stockholder (not including mutual funds) (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Sandeep Basavarajaiah, MD
No relationships to disclose
Donald E. Cutlip, MD, FACC
Vice Chair, Department of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Disclosure information not submitted.
Jean-Francois Tanguay, MD
Full professor of Medicine, Director, Interventional Cardiology
Montreal Heart Institute/ Univeristy of Montreal, Quebec, Canada
No relationships to disclose